NO20021948D0 - Contraceptive drug based on progesterone and estrogen and method of preparation thereof - Google Patents

Contraceptive drug based on progesterone and estrogen and method of preparation thereof

Info

Publication number
NO20021948D0
NO20021948D0 NO20021948A NO20021948A NO20021948D0 NO 20021948 D0 NO20021948 D0 NO 20021948D0 NO 20021948 A NO20021948 A NO 20021948A NO 20021948 A NO20021948 A NO 20021948A NO 20021948 D0 NO20021948 D0 NO 20021948D0
Authority
NO
Norway
Prior art keywords
progesterone
estrogen
preparation
drug based
contraceptive drug
Prior art date
Application number
NO20021948A
Other languages
Norwegian (no)
Other versions
NO20021948L (en
NO330885B1 (en
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021948(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of NO20021948D0 publication Critical patent/NO20021948D0/en
Publication of NO20021948L publication Critical patent/NO20021948L/en
Publication of NO330885B1 publication Critical patent/NO330885B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
NO20021948A 1999-10-25 2002-04-25 Use of a preparation comprising estradiol and nomegestrol acetate for the manufacture of a contraceptive product and a contraceptive product. NO330885B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002587 WO2001030355A1 (en) 1999-10-25 1999-10-25 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
PCT/FR2000/002952 WO2001030358A1 (en) 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same

Publications (3)

Publication Number Publication Date
NO20021948D0 true NO20021948D0 (en) 2002-04-25
NO20021948L NO20021948L (en) 2002-06-25
NO330885B1 NO330885B1 (en) 2011-08-08

Family

ID=9542725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021948A NO330885B1 (en) 1999-10-25 2002-04-25 Use of a preparation comprising estradiol and nomegestrol acetate for the manufacture of a contraceptive product and a contraceptive product.

Country Status (21)

Country Link
EP (2) EP2020236B1 (en)
JP (1) JP5484646B2 (en)
KR (1) KR100549625B1 (en)
CN (1) CN1205936C (en)
AP (1) AP1707A (en)
AU (1) AU784478B2 (en)
BR (1) BR0014952A (en)
CA (1) CA2388857C (en)
CR (1) CR6627A (en)
CZ (1) CZ301982B6 (en)
ES (1) ES2565688T3 (en)
HK (2) HK1048600A1 (en)
HU (1) HU230467B1 (en)
IL (2) IL149141A0 (en)
MX (1) MXPA02004083A (en)
NO (1) NO330885B1 (en)
NZ (1) NZ518308A (en)
OA (1) OA12071A (en)
RU (1) RU2258512C2 (en)
WO (2) WO2001030355A1 (en)
ZA (1) ZA200203399B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (en) 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
WO2001030356A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
FR2814074B1 (en) * 2000-09-15 2003-03-07 Theramex NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
KR100975350B1 (en) * 2002-11-29 2010-08-12 재단법인서울대학교산학협력재단 Transgenic cloned cow producing human lactoferricin and method for producing the same
PE20060378A1 (en) * 2004-07-07 2006-06-02 Wyeth Corp CYCLIC PROGESTIN KITS AND REGIMES
US8663681B2 (en) * 2005-05-26 2014-03-04 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
CN103877059A (en) * 2014-03-26 2014-06-25 邵娜 Nomegestrol acetate tablet and preparation process thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (en) 1986-07-15 2003-10-06 Wyeth Corp Use of a composition comprising an estrogen and a progestogen for the preparation of a dosage form to provide hormone replacement therapy and contraception for women during the premenopause and pack to provide the composition
HU214598B (en) 1987-09-24 1998-04-28 Jencap Research Ltd Process for producing contraceptive compositions containing estragen and progestin and applicable for hormonal therapy
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5532416A (en) 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE4344462C2 (en) 1993-12-22 1996-02-01 Schering Ag Composition for contraception
FR2737411B1 (en) * 1995-08-01 1997-10-17 Theramex NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES
DE19529767A1 (en) 1995-08-12 1997-02-13 Huels Chemische Werke Ag Amphiphilic compounds with several hydrophilic and hydrophobic groups based on amino succinic acid derivatives
US5902914A (en) 1995-08-14 1999-05-11 Alliedsignal Inc. Process for the preparation of halogenated alkanes
AUPN479995A0 (en) 1995-08-15 1995-09-07 Leon Kruss Technology Pty Limited Lightweight cementitious composition
US5654494A (en) 1995-08-18 1997-08-05 Alliedsignal Inc. Process for the manufacture of 1,1,1,2-tetrafluoroethane
US5530167A (en) 1995-08-21 1996-06-25 Eastman Chemical Company Process for the preparation of 1,4-butenediol
DE19536742A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle
DE19536745A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle, in particular a motor vehicle
DE19536744A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade with interchangeable wiper rubber for a vehicle wiper
WO1997012785A1 (en) 1995-10-02 1997-04-10 Nsk Ltd. Seat belt retractor
DE29515703U1 (en) 1995-10-02 1996-02-08 Föhl, Artur, 73614 Schorndorf Rotary drive device for a belt tensioner
EP0770338B1 (en) 1995-10-23 2002-09-25 Honda Access Corp. Cap body of a helmet
DE19540253C2 (en) 1995-10-28 1998-06-04 Jenapharm Gmbh Multi-phase preparation for contraception based on natural estrogens
DE19549264A1 (en) 1995-12-23 1997-06-26 Schering Ag Contraception procedure and kit
AU2815897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
FR2754179B1 (en) * 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
GB9621990D0 (en) 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19705229C2 (en) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
AU9028098A (en) 1997-08-27 1999-03-16 Ortho Pharmaceutical Corporation Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (en) 1997-09-11 2001-09-13 Hesch Rolf Dieter Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
CA2301162A1 (en) 1997-09-12 1999-03-25 Michael Jay Gast Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin

Also Published As

Publication number Publication date
NO20021948L (en) 2002-06-25
WO2001030355A1 (en) 2001-05-03
IL149141A0 (en) 2002-11-10
CN1205936C (en) 2005-06-15
HUP0203443A3 (en) 2003-12-29
EP1227815A1 (en) 2002-08-07
HK1048600A1 (en) 2003-04-11
JP5484646B2 (en) 2014-05-07
CZ301982B6 (en) 2010-08-25
HK1129564A1 (en) 2009-12-04
CZ20021426A3 (en) 2002-08-14
CR6627A (en) 2008-06-18
EP2020236B1 (en) 2016-01-27
EP2020236A1 (en) 2009-02-04
PL354518A1 (en) 2004-01-26
OA12071A (en) 2006-05-04
KR20020073333A (en) 2002-09-23
ES2565688T3 (en) 2016-04-06
RU2002113654A (en) 2004-01-27
IL149141A (en) 2008-06-05
NO330885B1 (en) 2011-08-08
CN1382054A (en) 2002-11-27
KR100549625B1 (en) 2006-02-08
AP1707A (en) 2007-02-26
AU1033501A (en) 2001-05-08
AP2002002485A0 (en) 2002-06-30
HU230467B1 (en) 2016-07-28
JP2003518013A (en) 2003-06-03
NZ518308A (en) 2006-01-27
HUP0203443A2 (en) 2003-01-28
WO2001030358A1 (en) 2001-05-03
RU2258512C2 (en) 2005-08-20
BR0014952A (en) 2003-07-29
MXPA02004083A (en) 2003-08-20
CA2388857C (en) 2011-06-07
CA2388857A1 (en) 2001-05-03
AU784478B2 (en) 2006-04-13
ZA200203399B (en) 2004-02-09

Similar Documents

Publication Publication Date Title
NO20002635D0 (en) Preparation of sterol and stanol esters
NO20014504L (en) Device and method for rehabilitation of tinnitus
NO20012047L (en) Drug delivery system, especially for the delivery of progestins and estrogens
AU1766599A (en) Progesterone tablet and preparation method
AU7350600A (en) Inpsb/inas bjt device and method of making
NO20030954D0 (en) Method of Increasing Testosterone and Related Steroid Concentrations in Women
DK1242012T3 (en) Improved transdermal contraceptive delivery system and method
AU2458202A (en) Flare measuring method and flare measuring device, exposure method and exposure system, method of adjusting exposure system
HUP0102498A3 (en) Transdermal therapeutic system containing steroid hormones and crystallization inhibitors
EP1180693A4 (en) Sensor device and method of manufacture thereof
DE60223795D1 (en) TETRAHYDROXYLATED ESTROGEN-CONTAINING DRUG DISPOSAL SYSTEM FOR USE IN HORMONAL CONTRACEPTION
NO20021948D0 (en) Contraceptive drug based on progesterone and estrogen and method of preparation thereof
AU2692500A (en) Semiconductor device and method of manufacture thereof
WO2000043408A3 (en) Steroid sulfatase inhibitors and methods for making and using the same
NO971449D0 (en) New hormonal drugs and their use for the correction of estrogen deficiency
NO991593D0 (en) Hormone preparation consisting of a ° estrogen compound and a progesterone compound
IL127129A0 (en) Method of preparation of progesterone tablet for vaginal delivery and tablets so prepared
AU2002217841A1 (en) Neuroactive steroid derivatives and methods of use
EP1111686A4 (en) Semiconductor device and method of manufacture thereof
EP1146573A4 (en) Semiconductor device and method of manufacture thereof
NO20020999D0 (en) Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone-dependent gynecological diseases
AU2001247205A1 (en) Estrogen receptor beta variants and methods of detection thereof
AU2001294947A1 (en) Method and apparatus for temporarily immobilizing a local area of tissue
AU9564998A (en) Device and method for creating and maintaining a rigid erection of a penis
AU4778400A (en) Exposure system and method of manufacturing device

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAMEX HQ UK LIMITED, GB

MK1K Patent expired